FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between International Gemmological Institute IPO and Suraksha Diagnostic IPO.
International Gemmological Institute IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Suraksha Diagnostic IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
International Gemmological Institute IPO | Suraksha Diagnostic IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Kotak Mahindra Capital Company Limited Morgan Stanley India Company Pvt Ltd SBI Capital Markets Limited |
ICICI Securities Limited Nuvama Wealth Management Limited SBI Capital Markets Limited |
Registrar | Kfin Technologies Limited | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL |
The total issue size of International Gemmological Institute IPO is up to ₹4,225.00 Cr whereas the issue size of the Suraksha Diagnostic IPO is up to ₹846.25 Cr. The final issue price of International Gemmological Institute IPO is and of Suraksha Diagnostic IPO is ₹441.00 per share.
International Gemmological Institute IPO | Suraksha Diagnostic IPO | |
---|---|---|
Face Value | ₹2 per share | ₹2 per share |
Issue Price (Lower) | ₹397.00 per share | ₹420.00 per share |
Issue Price (Upper) | ₹417.00 per share | ₹441.00 per share |
Issue Price (Final) | ₹441.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 35 shares | 34 shares |
Fresh Issue Size | 3,53,71,702 shares | |
Fresh Issue Size (Amount) | up to ₹1,475.00 Cr | |
OFS Issue Size | 6,59,47,242 shares | 1,91,89,330 shares |
OFS Issue Size (Amount) | up to ₹2,750.00 Cr | up to ₹846.25 Cr |
Issue Size Total | 10,13,18,944 shares | 1,91,89,330 shares |
Issue Size Total (Amount) | up to ₹4,225.00 Cr | up to ₹846.25 Cr |
International Gemmological Institute IPO opens on Dec 13, 2024, while Suraksha Diagnostic IPO opens on Nov 29, 2024. The closing date of International Gemmological Institute IPO and Suraksha Diagnostic IPO is Dec 17, 2024, and Dec 03, 2024, respectively.
International Gemmological Institute IPO | Suraksha Diagnostic IPO | |
---|---|---|
Anchor Bid Date | Dec 12, 2024 | Nov 28, 2024 |
Issue Open | Dec 13, 2024 | Nov 29, 2024 |
Issue Close | Dec 17, 2024 | Dec 03, 2024 |
Basis Of Allotment (Tentative) | Dec 18, 2024 | Dec 04, 2024 |
Initiation of Refunds (Tentative) | Dec 19, 2024 | Dec 05, 2024 |
Credit of Share (Tentative) | Dec 19, 2024 | Dec 05, 2024 |
Listing date (Tentative) | Dec 20, 2024 | Dec 06, 2024 |
Anchor Lockin End date 1 | Jan 17, 2025 | Jan 03, 2025 |
Anchor Lockin End date 2 | Mar 18, 2025 | Mar 04, 2025 |
International Gemmological Institute IPO P/E ratio is , as compared to Suraksha Diagnostic IPO P/E ratio of 99.31.
International Gemmological Institute IPO | Suraksha Diagnostic IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | International Gemmological Institute (India) Limited Financial Information (Restated)
|
Suraksha Diagnostic Limited Financial Information (Restated Consolidated)Suraksha Diagnostic Limited's revenue increased by 14.75% and profit after tax (PAT) rose by 281.32% between the financial year ending with March 31, 2024 and March 31, 2023.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 61.07% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 76.55% | 48.78% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 99.31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹2296.76 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 76.58%% | 14.09%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 80.96%% | 21.46%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 76.58%% | 14.09%% |
In the International Gemmological Institute IPO retail investors (RII) are offered while in Suraksha Diagnostic IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in International Gemmological Institute IPO and 38,37,867 shares in Suraksha Diagnostic IPO.
International Gemmological Institute IPO | Suraksha Diagnostic IPO | |
---|---|---|
Anchor Investor Reserveration | 57,56,797 shares | |
Market Maker Reserveration | ||
QIB | 38,37,867 shares | |
NII | 28,78,400 shares | |
RII | 67,16,266 shares | |
Employee | 0 shares | |
Others | ||
Total | 1,34,32,533 shares |
International Gemmological Institute IPO subscribed in total, whereas Suraksha Diagnostic IPO subscribed 1.27x.
International Gemmological Institute IPO | Suraksha Diagnostic IPO | |
---|---|---|
QIB (times) | 1.74x | |
NII (times) | 1.40x | |
Big NII (times) | 1.53x | |
Small NII (times) | 1.16x | |
RII (times) | 0.94x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.27x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|